Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RACB
2776
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
| $490K | ﹤0.01% |
+50,000
| New | +$489K |
|
|
EMBJ
2777
Embraer S.A. ADS
EMBJ
$13B
| $488K | ﹤0.01% |
55,600
+48,056
| +637% | +$514K |
|
|
KREF
2778
KKR Real Estate Finance Trust
KREF
$464M
| $488K | ﹤0.01% |
27,984
-37,277
| -57% | -$719K |
|
2779
RUM Group Inc
RUM
$1.71B
| $488K | ﹤0.01% |
48,897
+23,897
| +96% | +$261K |
|
2780
Southside Bancshares
SBSI
$974M
| $488K | ﹤0.01% |
13,056
-30,396
| -70% | -$1.18M |
|
|
CCRN
2781
DELISTED
Cross Country Healthcare
CCRN
| $486K | ﹤0.01% |
23,335
-15,044
| -39% | -$282K |
|
2782
HealthEquity
HQY
$8.73B
| $486K | ﹤0.01% |
7,912
-7,761
| -50% | -$497K |
|
2783
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.9B
| $486K | ﹤0.01% |
2,770
| – | – |
|
2784
MACOM Technology Solutions
MTSI
$20.1B
| $485K | ﹤0.01% |
10,540
+198
| +2% | +$10.2K |
|
2785
Talos Energy
TALO
$2.37B
| $483K | ﹤0.01% |
31,234
-59,568
| -66% | -$1.16M |
|
2786
Banc of California
BANC
$3.07B
| $482K | ﹤0.01% |
27,306
-66,801
| -71% | -$1.22M |
|
|
DVAX
2787
DELISTED
Dynavax Technologies
DVAX
| $482K | ﹤0.01% |
38,266
-79,287
| -67% | -$842K |
|
2788
Standard Motor Products
SMP
$884M
| $481K | ﹤0.01% |
10,708
-8,934
| -45% | -$371K |
|
|
IBER
2789
DELISTED
Ibere Pharmaceuticals
IBER
| $481K | ﹤0.01% |
+49,023
| New | +$481K |
|
2790
Palomar
PLMR
$3.55B
| $480K | ﹤0.01% |
7,468
-13,171
| -64% | -$795K |
|
2791
Iovance Biotherapeutics
IOVA
$1.94B
| $479K | ﹤0.01% |
43,415
-29,849
| -41% | -$391K |
|
2792
Dime Commercial Bancshares
DCOM
$1.83B
| $478K | ﹤0.01% |
16,119
+15,931
| +8,474% | +$507K |
|
2793
Accel Entertainment
ACEL
$1.01B
| $476K | ﹤0.01% |
44,853
-6,457
| -13% | -$72.2K |
|
|
BRKL
2794
DELISTED
Brookline Bancorp
BRKL
| $475K | ﹤0.01% |
35,675
-87,163
| -71% | -$1.25M |
|
2795
Kratos Defense & Security Solutions
KTOS
$10.4B
| $475K | ﹤0.01% |
34,255
-14,927
| -30% | -$232K |
|
|
RETA
2796
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $475K | ﹤0.01% |
15,631
-13,279
| -46% | -$396K |
|
2797
American Vanguard Corp
AVD
$73.2M
| $474K | ﹤0.01% |
21,224
-9,859
| -32% | -$221K |
|
2798
Cass Information Systems
CASS
$731M
| $474K | ﹤0.01% |
14,021
+11,711
| +507% | +$421K |
|
2799
Universal Corp
UVV
$1.3B
| $474K | ﹤0.01% |
7,839
-11,877
| -60% | -$708K |
|
|
EH
2800
EHang Holdings
EH
$406M
| $473K | ﹤0.01% |
51,134
+2,000
| +4% | +$18.8K |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 560 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 560 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.